Summary of Study ST003398
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002104. The data can be accessed directly via it's Project DOI: 10.21228/M8NJ9Q This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST003398 |
Study Title | Specific activation of the integrated stress response (ISR) uncovers regulation of lipid droplet biogenesis |
Study Type | Biology |
Study Summary | U2OS cells were treated with Dimerizer-PERK for 0h,1h,2h,4h,8h and 24h. Lipidomics analysis using LC-MS was performed on these samples to understand the regulation of cellular lipidome upon ISR activation |
Institute | Calico Life Sciences |
Department | Department of Mass Spectrometry-Technology Lab |
Laboratory | Metabolomics Lab |
Last Name | Vu |
First Name | Ngoc |
Address | 1130 Veterans BLVD, South San Francisco, CA 94080 |
ngoc@calicolabs.com | |
Phone | 650-420-5430 |
Submit Date | 2024-08-08 |
Num Groups | 6 |
Total Subjects | 18 |
Raw Data Available | Yes |
Raw Data File Type(s) | mzML |
Analysis Type Detail | LC-MS |
Release Date | 2024-09-03 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR003532 |
Treatment Summary: | U2OS cells were treated with 0.05nM of dimerizer over the course of 0,1,2,4,8,24 hours for lipidomics analysis |
Treatment Compound: | DImerizer AP20187 |
Treatment Dose: | 0.05 nM to media |
Treatment Doseduration: | 0h,1h,2h,4h,8h,24h |
Treatment Vehicle: | ethanol |
Cell Growth Container: | 6-well plate |
Cell Growth Config: | U2OS cells were grown in Dulbecco’s modified Eagle’s medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS, Sigma) and 1X antibiotic-antimycotic solution (Gibco). Cells were housed in an incubator at 37°C, 5% CO2, 20% O2 and passaged every 2-3 days with trypsin. |
Cell Media: | U2OS cells were grown in Dulbecco’s modified Eagle’s medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS, Sigma) and 1X antibiotic-antimycotic solution (Gibco). |
Cell Harvesting: | LLE-MTBE (Matyash) |
Cell Pct Confluence: | 80% |
Cell Media Lastchanged: | 24 hours prior to harvesting |